14 Schoolhouse Road
+1 866 720 3148
Catalent offers the broadest range of services and technologies to transform your molecule into a successful treatment — from specific challenges, tailored solutions or fully-integrated support.
Catalent is the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With more than 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal year 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey.
Given Catalent’s expertise and capacity, our experts can enter the process at any stage in your product’s lifecycle. That’s why we like you to start thinking about protecting your brand and improving product early in our partnership so we can add value and differentials from the start.
With our broad range of expert services – including analytical, biologics, preformulation, and formulation – we drive faster, more efficient development timelines and produce better products. Our robust GPEx mammalian cell line engineering technology accelerates large molecule drugs from discovery to clinic, and our unique Optiform technology ensures maximum API optimisation. With our deep expertise and our extensive formulation capabilities in oral dose forms, controlled release, inhaled dose forms and softgel technologies, we can solve even the most complex bioavailability, solubility, and permeability challenges.
We are a world leader in drug delivery solutions with a proven track record of helping our customers create better treatments by boosting bioavailability, solubility, and permeability; improving ease and route of administration; and increasing patient compliance. Our unique delivery technologies – including softgel solutions, Liqui-Gels capsules, and Vegicaps capsules, Zydis fast dissolve, controlled release, and inhaled dose forms – improve how products work in and for patients.
As a seamless extension of your supply chain, we have the technology and expertise to offer global, integrated manufacturing and packaging solutions to take your product from design to clinical trial, plant, and pharmacy. We manufacture oral, sterile, and inhaled dose forms, produce biologics for preclinical and clinical studies, and are the recognized leader in biotechnology product packaging.
OmegaZero; EasyBurst; Vegicaps; Graphicaps.
Polysorbate-80 (PS-80) is a surfactant commonly used as an excipient to improve API stability. Degradation can lead to decreased potency. This case study describes how to quantitate and characterize #PS80 formulations. Download here: https://t.co/CT0CMGlhv4 pic.twitter.com/W1Ad2114zl— Catalent Pharma (@CatalentPharma) August 22, 2019
I‘m in #Windsor with major employers+exporters, like @CatalentPharma. Did you know that Ibuprofen was made in Windsor, ON? They supply 1/20 of gel capsules in the world & have 10 manufacturing sites around the world, 2 of which are here in Ontario. #TimeToDiversify #cdnpoli pic.twitter.com/sEXjCiTll1— Omar Alghabra (@OmarAlghabra) August 22, 2019